Literature DB >> 3950625

Acetylcholine transport and drug inhibition kinetics in Torpedo synaptic vesicles.

B A Bahr, S M Parsons.   

Abstract

Steady-state initial velocity uptake of [3H]acetylcholine ([3H]ACh) by purified Torpedo electric organ synaptic vesicles was studied. Transport specific activity decreased at higher vesicle concentration. Michaelis-Menten type kinetics describe [3H]ACh active transport at constant vesicle concentration with no evidence of cooperativity or transporter heterogeneity. The ACh dissociation constant is about 0.3 mM, transport has a maximal velocity of about 1.6 nmol/min/mg protein, and both are dependent on the vesicle preparation. Nonradioactive ACh was a competitive inhibitor with respect to [3H]ACh. The potent transport inhibitor dl-trans-2-(4-phenylpiperidino)cyclohexanol (AH5183) is a non-competitive inhibitor with respect to [3H]ACh, with an inhibition constant of 41 +/- 7 nM. Inhibition by AH5183 is reversible. The results suggest that AH5183 does not bind to the ACh transporter recognition site on the outside of the vesicle membrane, and thus it might inhibit allosterically.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950625     DOI: 10.1111/j.1471-4159.1986.tb00640.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Acetylcholine release and the cholinergic genomic locus.

Authors:  M Israël; Y Dunant
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

2.  Specificity of the rat vesicular acetylcholine transporter.

Authors:  Myung-Hee Kim; Mei Lu; Gary Rogers; Stanley Parsons; Louis B Hersh
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

3.  In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter.

Authors:  Prashanth K Padakanti; Xiang Zhang; Hongjun Jin; Jinquan Cui; Ruike Wang; Junfeng Li; Hubert P Flores; Stanley M Parsons; Joel S Perlmutter; Zhude Tu
Journal:  Mol Imaging Biol       Date:  2014-12       Impact factor: 3.488

4.  Synthesis and biological characterization of a promising F-18 PET tracer for vesicular acetylcholine transporter.

Authors:  Zhude Tu; Xiang Zhang; Hongjun Jin; Xuyi Yue; Prashanth K Padakanti; Lihai Yu; Hui Liu; Hubert P Flores; Kota Kaneshige; Stanley M Parsons; Joel S Perlmutter
Journal:  Bioorg Med Chem       Date:  2015-06-05       Impact factor: 3.641

5.  Possible important pair of acidic residues in vesicular acetylcholine transporter.

Authors:  Parul Khare; Ana M Ojeda; Ananda Chandrasekaran; Stanley M Parsons
Journal:  Biochemistry       Date:  2010-04-13       Impact factor: 3.162

Review 6.  Vesicular neurotransmitter transporters. Potential sites for the regulation of synaptic function.

Authors:  H Varoqui; J D Erickson
Journal:  Mol Neurobiol       Date:  1997-10       Impact factor: 5.590

7.  Increasing quantal size at the mouse neuromuscular junction and the role of choline.

Authors:  S P Yu; W Van der Kloot
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

8.  Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).

Authors:  M R Marien; S M Parsons; C A Altar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

9.  Multiple protonation states of vesicular acetylcholine transporter detected by binding of [3H]vesamicol.

Authors:  Parul Khare; Aubrey R White; Stanley M Parsons
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

10.  Effect of Dopamine D2 Receptor Antagonists on [18F]-FEOBV Binding.

Authors:  Anna Schildt; Erik F J de Vries; Antoon T M Willemsen; Bruno Lima Giacobbo; Rodrigo Moraga-Amaro; Jürgen W A Sijbesma; Aren van Waarde; Vesna Sossi; Rudi A J O Dierckx; Janine Doorduin
Journal:  Mol Pharm       Date:  2020-02-17       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.